2008年至2023年萨库比特里尔/瓦尔萨坦研究的知识领域和新兴趋势 - 基于新型科学计量工具的可视化结论性分析
1Cardiovascular Department, Ningbo Hangzhou Bay Hospital, Ningbo, China. jiachengrong@sjtu.edu.cn.
European review for medical and pharmacological sciences
|February 2, 2024
概括
图书统计分析显示,萨库比特里尔/瓦尔沙坦 (Entresto) 的研究趋势越来越强. 未来的研究将专注于新的治疗机制和扩展应用这个血管激素受体-尼普利辛抑制剂 (ARNI).
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 图书统计学 图书统计学
背景情况:
- 一种血管激素受体-尼普利辛抑制剂 (ARNI) 的萨库比特里尔/瓦尔沙坦已经成为一种重要的治疗药物.
- 了解sacubitril/valsartan的研究环境对于推进心血管医学至关重要.
研究的目的:
- 量化和定性地分析sacubitril/valsartan研究的演变.
- 确定该领域的关键趋势,作者,机构和出版物.
- 为利用ARNI疗法提供参考.
主要方法:
- 使用CiteSpace和VOSviewer进行图书统计分析.
- 识别顶级作者,国家,机构和共同引用的参考文献.
- 关键词分析和引文爆发检测.
主要成果:
- 从2008年到2022年,萨库比特里尔/瓦尔萨坦的引用显示出显著的上升趋势.
- 关键词分析揭示了七个不同的研究集群,突出了Entresto的新应用和与其他疗法的组合.
- 引用爆发分析表明,一个新的研究时代,专注于扩展应用和组合疗法.
结论:
- 未来对萨库比特里尔/瓦尔沙坦的研究很可能会集中在针对特定疾病途径的新机制上.
- 预计将探索扩大治疗目标和创新的组合策略.
相关概念视频
Structure-Activity Relationships and Drug Design
721
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
721
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
229
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
229
Current Trends in Nursing II
1.2K
Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
1.2K
Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Antihypertensive Drugs: Direct Renin Inhibitors
630
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
630


